Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 22 April, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Arvee Laboratories (India) Ltd

About the Company - Arvee Laboratories (India) Ltd

Arvee Laboratories (India) Ltd. is a Public Limited Listed company incorporated on 27/01/2012 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24231GJ2012PLC068778 and registration number is 068778. Currently company belongs to the Industry of Chemicals - Speciality - Others. Company’s Total Operating Revenue is Rs. 40.33 Cr. and Equity Capital is Rs. 11.02 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Chemicals - Speciality - Others403, Entice, Nr. Jayantilal Park BRTS, Ahmedabad Gujarat 380058compliance@arveelabs.com
http://www.arveelabs.com
Management
NamePosition Held
Mr. Shalin Sudhakarbhai PatelManaging Director
Mr. Shalin Bharat ChokshiWhole Time Director
Mrs. Neetu Rishi JalanIndependent Director
Mr. Dipen Ashit DalalIndependent Director
Mr. Sachin Kanwarlal KansalIndependent Director
Ms. Shalini Hitesh JalanAdditional Director

Arvee Laboratories (India) Ltd. Share Price Update

Share PriceValue
Today₹237.35
Previous Day₹249.85

Basic Stock Data of Arvee Laboratories (India) Ltd

Last Updated: April 8, 2024, 5:08 am

Market Cap 279 Cr.
Current Price 254
High / Low254/98.1
Stock P/E294
Book Value 26.1
Dividend Yield0.00 %
ROCE23.3 %
ROE15.8 %
Face Value 10.0

Data Source: screener.in

Arvee Laboratories (India) Ltd Quarterly Results

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales19.948.859.0610.707.9012.6718.1822.7416.2512.567.608.917.70
Expenses17.337.817.639.006.8911.1315.9219.4814.5111.406.628.227.17
Operating Profit2.611.041.431.701.011.542.263.261.741.160.980.690.53
OPM %13.09%11.75%15.78%15.89%12.78%12.15%12.43%14.34%10.71%9.24%12.89%7.74%6.88%
Other Income0.130.290.060.070.120.210.020.060.070.060.090.090.19
Interest0.110.090.120.060.090.090.110.110.090.070.070.080.05
Depreciation0.590.620.660.670.380.620.640.480.490.480.350.420.35
Profit before tax2.040.620.711.040.661.041.532.731.230.670.650.280.32
Tax %25.00%30.65%25.35%29.81%-74.24%24.04%24.84%25.27%25.20%100.00%24.62%25.00%25.00%
Net Profit1.530.430.530.731.160.791.142.050.920.010.490.210.24
EPS in Rs1.390.390.480.661.050.721.031.860.830.010.440.190.22

Last Updated: April 6, 2024, 9:26 am

Arvee Laboratories (India) Ltd Quarterly Chart

Arvee Laboratories (India) Ltd Profit & Loss

Month

Arvee Laboratories (India) Ltd Profit & Loss Yearly Chart

Arvee Laboratories (India) Ltd Growth

Compounded Sales Growth
10 Years:%
5 Years:5%
3 Years:11%
TTM:-47%
Compounded Profit Growth
10 Years:%
5 Years:30%
3 Years:24%
TTM:-81%
Stock Price CAGR
10 Years:%
5 Years:53%
3 Years:43%
1 Year:101%
Return on Equity
10 Years:%
5 Years:13%
3 Years:13%
Last Year:16%

Last Updated: April 8, 2024, 5:08 am

Arvee Laboratories (India) Ltd Balance Sheet

MonthMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital4.054.055.515.515.5111.0211.0211.0211.02
Reserves-1.410.158.6910.9513.2510.4212.9217.0417.74
Borrowings25.3224.9916.1512.873.878.883.131.001.00
Other Liabilities7.256.4913.777.8111.0010.7311.619.635.03
Total Liabilities35.2135.6844.1237.1433.6341.0538.6838.6934.79
Fixed Assets13.1516.8814.8812.6513.1813.8113.8412.6812.99
CWIP4.300.001.182.321.780.970.981.532.06
Investments0.000.000.001.953.092.030.000.000.00
Other Assets17.7618.8028.0620.2215.5824.2423.8624.4819.74
Total Assets35.2135.6844.1237.1433.6341.0538.6838.6934.79

Arvee Laboratories (India) Ltd Reserves and Borrowings Chart

Arvee Laboratories (India) Ltd Cash Flow

MonthMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 4.036.029.4610.311.710.682.93
Cash from Investing Activity -1.40-1.23-2.85-3.08-0.600.06-1.26
Cash from Financing Activity -2.92-3.78-4.92-9.904.52-6.06-2.42
Net Cash Flow-0.291.001.68-2.675.63-5.32-0.75

Arvee Laboratories (India) Ltd Financial Efficiency Indicators

MonthMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days82.6187.12118.2552.6652.4060.70109.7872.94
Inventory Days155.08104.5399.6142.9080.9691.9693.2442.29
Days Payable130.7398.14150.0355.84125.63118.08160.1273.30
Cash Conversion Cycle106.9693.5067.8439.727.7234.5942.9041.94
Working Capital Days115.54107.5782.7344.8825.6450.0769.2470.44
ROCE %15.19%17.64%13.67%14.90%14.92%12.89%23.34%

Arvee Laboratories (India) Ltd Financial Efficiency Indicators Chart

No valid data available for the Shareholding

Arvee Laboratories (India) Ltd Shareholding Pattern Chart

No. of Arvee Laboratories (India) Ltd Shareholders

This stock is not held by any mutual fund

Arvee Laboratories (India) Ltd ROCE Trend

Arvee Laboratories (India) Ltd EPS Trend

Arvee Laboratories (India) Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)3.742.342.434.044.11
Diluted EPS (Rs.)3.742.342.434.044.11
Cash EPS (Rs.)5.634.444.618.208.37
Book Value[Excl.RevalReserv]/Share (Rs.)25.4621.7319.4533.9229.88
Book Value[Incl.RevalReserv]/Share (Rs.)25.4621.7319.4533.9229.88
Revenue From Operations / Share (Rs.)56.7036.5942.9982.4399.64
PBDIT / Share (Rs.)7.835.566.0111.5611.85
PBIT / Share (Rs.)5.953.463.837.407.58
PBT / Share (Rs.)5.593.133.305.614.62
Net Profit / Share (Rs.)3.742.342.434.044.11
PBDIT Margin (%)13.8115.1913.9814.0111.89
PBIT Margin (%)10.489.448.908.977.60
PBT Margin (%)9.868.557.686.804.63
Net Profit Margin (%)6.596.385.654.904.12
Return on Networth / Equity (%)14.6710.7512.4811.9113.74
Return on Capital Employeed (%)22.1715.1418.5319.3520.38
Return On Assets (%)10.646.656.526.626.09
Long Term Debt / Equity (X)0.030.040.040.100.21
Total Debt / Equity (X)0.030.130.410.110.68
Asset Turnover Ratio (%)1.621.011.271.281.35
Current Ratio (X)2.621.751.401.441.29
Quick Ratio (X)2.121.330.990.921.01
Inventory Turnover Ratio (X)7.483.534.185.465.98
Interest Coverage Ratio (X)22.2617.0811.496.454.00
Interest Coverage Ratio (Post Tax) (X)11.628.175.643.252.38
Enterprise Value (Cr.)94.72123.8063.3227.0942.26
EV / Net Operating Revenue (X)1.523.071.340.590.76
EV / EBITDA (X)10.9720.209.564.256.47
MarketCap / Net Operating Revenue (X)1.553.111.290.570.63
Price / BV (X)3.465.232.851.392.11
Price / Net Operating Revenue (X)1.553.111.290.570.63
EarningsYield0.040.020.040.080.06

Arvee Laboratories (India) Ltd Profitability Ratios (%)

Arvee Laboratories (India) Ltd Liquidity Ratios

Arvee Laboratories (India) Ltd Liquidity Ratios (%)

Arvee Laboratories (India) Ltd Interest Coverage Ratios (%)

Arvee Laboratories (India) Ltd Valuation Ratios

Strength and Weakness of Arvee Laboratories (India) Ltd Stock

Unable to fetch valid data for stock valuation.

FAQ

What is the latest fair value of Arvee Laboratories (India) Ltd?

The latest fair value of Arvee Laboratories (India) Ltd is 0.00.

What is the Market Cap of Arvee Laboratories (India) Ltd?

The Market Cap of Arvee Laboratories (India) Ltd is 279 Cr..

What is the current Stock Price of Arvee Laboratories (India) Ltd as on 17 April 2024?

The current stock price of Arvee Laboratories (India) Ltd as on 17 April 2024 is 254.

What is the High / Low of Arvee Laboratories (India) Ltd stocks in FY 2024?

In FY 2024, the High / Low of Arvee Laboratories (India) Ltd stocks is ₹254/98.1.

What is the Stock P/E of Arvee Laboratories (India) Ltd?

The Stock P/E of Arvee Laboratories (India) Ltd is 294.

What is the Book Value of Arvee Laboratories (India) Ltd?

The Book Value of Arvee Laboratories (India) Ltd is 26.1.

What is the Dividend Yield of Arvee Laboratories (India) Ltd?

The Dividend Yield of Arvee Laboratories (India) Ltd is 0.00 %.

What is the ROCE of Arvee Laboratories (India) Ltd?

The ROCE of Arvee Laboratories (India) Ltd is 23.3 %.

What is the ROE of Arvee Laboratories (India) Ltd?

The ROE of Arvee Laboratories (India) Ltd is 15.8 %.

What is the Face Value of Arvee Laboratories (India) Ltd?

The Face Value of Arvee Laboratories (India) Ltd is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Arvee Laboratories (India) Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE